Clinica Chimica Acta:MP-IgG定量检测对成人肺炎支原体肺炎的诊断价值

2020-04-13 MedSci原创 MedSci原创

曾被广泛用于肺炎支原体(M.pneumoniae)抗体检测的被动颗粒凝集(PA)试验,现在已逐渐被定量酶联免疫吸附法(ELISA)所取代。然而,由于缺乏定量ELISA肺炎杆菌-IgG(MP-IgG)的

曾被广泛用于肺炎支原体(M.pneumoniae)抗体检测的被动颗粒凝集(PA)试验,现在已逐渐被定量酶联免疫吸附法(ELISA)所取代。然而,由于缺乏定量ELISA肺炎杆菌-IgG(MP-IgG)的诊断标准,以及ELISA肺炎杆菌-IgM(MP-IgM)的阳性率较低,限制了ELISA对成人肺炎杆菌感染的诊断价值。

在此,研究人员对肺炎支原体肺炎支原体肺炎(MP-IgG)在成人肺炎支原体肺炎(MPP)中的诊断价值进行了定量ELISA MP-IgG的评估。以PA结果为参考标准,在162例MPP患者、228例社区获得性肺炎(CAP)非肺炎支原体肺炎(NMP)患者和162例健康对照组患者中,通过ELISA法检测到血清M. 对于MP-IgM-/IgG+亚组,单次血清MP-IgG水平≥92.67 RU/mL可作为急性肺炎支原体感染的诊断参考标准。入院时,对于CAP患者,ELISA MP-IgM阳性的MPP的敏感性和特异性分别为18.51%和99.56%。MP-IgM阳性联合MP-IgG≥92.67 RU/mL,敏感性提高到40.12%,特异性降低到94.29%。对于7天内获得的配对血清样本,ELISA法MP-IgG浓度变化≥1.48倍,第7天MP-IgG≥92.67 RU/mL作为肺炎杆菌感染的诊断标准。

因此,ELISA法结合MP-IgM定性检测和MP-IgG定量检测对成人急性MPP的诊断具有重要价值。

原始出处:

Lina Wu,Maosheng Ye,Diagnostic value of quantitative MP-IgG for Mycoplasma pneumoniae pneumonia in adults

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1721687, encodeId=46a21e21687c8, content=<a href='/topic/show?id=39d6915e9bf' target=_blank style='color:#2F92EE;'>#诊断价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91579, encryptionId=39d6915e9bf, topicName=诊断价值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c7d33065043, createdName=medscijoin, createdTime=Wed Oct 28 15:15:06 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849921, encodeId=b4951849921c4, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Fri May 29 21:15:06 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614723, encodeId=38c31614e2387, content=<a href='/topic/show?id=1f0a5e0662f' target=_blank style='color:#2F92EE;'>#支原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57066, encryptionId=1f0a5e0662f, topicName=支原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fb019527746, createdName=ms5906905816781247, createdTime=Tue Apr 14 23:15:06 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615214, encodeId=7150161521451, content=<a href='/topic/show?id=010c9506a3' target=_blank style='color:#2F92EE;'>#IgG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9506, encryptionId=010c9506a3, topicName=IgG)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c4f19588882, createdName=ms5768352621950538, createdTime=Tue Apr 14 23:15:06 CST 2020, time=2020-04-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1721687, encodeId=46a21e21687c8, content=<a href='/topic/show?id=39d6915e9bf' target=_blank style='color:#2F92EE;'>#诊断价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91579, encryptionId=39d6915e9bf, topicName=诊断价值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c7d33065043, createdName=medscijoin, createdTime=Wed Oct 28 15:15:06 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849921, encodeId=b4951849921c4, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Fri May 29 21:15:06 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614723, encodeId=38c31614e2387, content=<a href='/topic/show?id=1f0a5e0662f' target=_blank style='color:#2F92EE;'>#支原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57066, encryptionId=1f0a5e0662f, topicName=支原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fb019527746, createdName=ms5906905816781247, createdTime=Tue Apr 14 23:15:06 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615214, encodeId=7150161521451, content=<a href='/topic/show?id=010c9506a3' target=_blank style='color:#2F92EE;'>#IgG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9506, encryptionId=010c9506a3, topicName=IgG)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c4f19588882, createdName=ms5768352621950538, createdTime=Tue Apr 14 23:15:06 CST 2020, time=2020-04-14, status=1, ipAttribution=)]
    2020-05-29 windight
  3. [GetPortalCommentsPageByObjectIdResponse(id=1721687, encodeId=46a21e21687c8, content=<a href='/topic/show?id=39d6915e9bf' target=_blank style='color:#2F92EE;'>#诊断价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91579, encryptionId=39d6915e9bf, topicName=诊断价值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c7d33065043, createdName=medscijoin, createdTime=Wed Oct 28 15:15:06 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849921, encodeId=b4951849921c4, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Fri May 29 21:15:06 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614723, encodeId=38c31614e2387, content=<a href='/topic/show?id=1f0a5e0662f' target=_blank style='color:#2F92EE;'>#支原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57066, encryptionId=1f0a5e0662f, topicName=支原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fb019527746, createdName=ms5906905816781247, createdTime=Tue Apr 14 23:15:06 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615214, encodeId=7150161521451, content=<a href='/topic/show?id=010c9506a3' target=_blank style='color:#2F92EE;'>#IgG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9506, encryptionId=010c9506a3, topicName=IgG)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c4f19588882, createdName=ms5768352621950538, createdTime=Tue Apr 14 23:15:06 CST 2020, time=2020-04-14, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1721687, encodeId=46a21e21687c8, content=<a href='/topic/show?id=39d6915e9bf' target=_blank style='color:#2F92EE;'>#诊断价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91579, encryptionId=39d6915e9bf, topicName=诊断价值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c7d33065043, createdName=medscijoin, createdTime=Wed Oct 28 15:15:06 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849921, encodeId=b4951849921c4, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Fri May 29 21:15:06 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614723, encodeId=38c31614e2387, content=<a href='/topic/show?id=1f0a5e0662f' target=_blank style='color:#2F92EE;'>#支原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57066, encryptionId=1f0a5e0662f, topicName=支原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fb019527746, createdName=ms5906905816781247, createdTime=Tue Apr 14 23:15:06 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615214, encodeId=7150161521451, content=<a href='/topic/show?id=010c9506a3' target=_blank style='color:#2F92EE;'>#IgG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9506, encryptionId=010c9506a3, topicName=IgG)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c4f19588882, createdName=ms5768352621950538, createdTime=Tue Apr 14 23:15:06 CST 2020, time=2020-04-14, status=1, ipAttribution=)]